2016
J. - S. Vidal, Hanon, O., Funalot, B., Brunel, N., Viollet, C., Rigaud, A. - S., Seux, M. - L., le-Bouc, Y., Epelbaum, J., and Duron, E.,
“Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer's Disease.”,
J Alzheimers Dis, vol. 52, no. 2, pp. 641-9, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P.,
“MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”,
J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
P. Pastor, Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munain, A. López, Bullido, M. J., de Pancorbo, M. M., Carro, E., Antonell, A., Coto, E., Ortega-Cubero, S., Hernandez, I., Tárraga, L., Boada, M., Lleo, A., Dols-Icardo, O., Kulisevsky, J., Vázquez-Higuera, J. Luis, Infante, J., Rábano, A., Fernández-Blázquez, M. Ángel, Valentí, M., Indakoetxea, B., Barandiarán, M., Gorostidi, A., Frank-García, A., Sastre, I., Lorenzo, E., Pastor, M. A., Elcoroaristizabal, X., Lennarz, M., Maier, W., Rámirez, A., Serrano-Ríos, M., Lee, S. E., and Sánchez-Juan, P.,
“MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.”,
J Alzheimers Dis, vol. 49, no. 2, pp. 343-52, 2016.
P. Adam, Křížková, S., Heger, Z., Babula, P., Pekařík, V., Vaculovičoá, M., Gomes, C. M., Kizek, R., and Adam, V.,
“Metallothioneins in Prion- and Amyloid-Related Diseases.”,
J Alzheimers Dis, vol. 51, no. 3, pp. 637-56, 2016.
P. Iso-Markku, Waller, K., Vuoksimaa, E., Heikkilä, K., Rinne, J., Kaprio, J., and Kujala, U. M.,
“Midlife Physical Activity and Cognition Later in Life: A Prospective Twin Study.”,
J Alzheimers Dis, vol. 54, no. 4, pp. 1303-1317, 2016.
K. Hoffmann, Sobol, N. A., Frederiksen, K. S., Beyer, N., Vogel, A., Vestergaard, K., Brændgaard, H., Gottrup, H., Lolk, A., Wermuth, L., Jacobsen, S., Laugesen, L. P., Gergelyffy, R. G., Høgh, P., Bjerregaard, E., Andersen, B. B., Siersma, V., Johannsen, P., Cotman, C. W., Waldemar, G., and Hasselbalch, S. G.,
“Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 443-53, 2016.
K. Hoffmann, Sobol, N. A., Frederiksen, K. S., Beyer, N., Vogel, A., Vestergaard, K., Brændgaard, H., Gottrup, H., Lolk, A., Wermuth, L., Jacobsen, S., Laugesen, L. P., Gergelyffy, R. G., Høgh, P., Bjerregaard, E., Andersen, B. B., Siersma, V., Johannsen, P., Cotman, C. W., Waldemar, G., and Hasselbalch, S. G.,
“Moderate-to-High Intensity Physical Exercise in Patients with Alzheimer's Disease: A Randomized Controlled Trial.”,
J Alzheimers Dis, vol. 50, no. 2, pp. 443-53, 2016.
I. Blockx, Einstein, S., Guns, P. - J., Van Audekerke, J., Guglielmetti, C., Zago, W., Roose, D., Verhoye, M., Van der Linden, A., and Bard, F.,
“Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 723-35, 2016.
I. Blockx, Einstein, S., Guns, P. - J., Van Audekerke, J., Guglielmetti, C., Zago, W., Roose, D., Verhoye, M., Van der Linden, A., and Bard, F.,
“Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 723-35, 2016.
I. Blockx, Einstein, S., Guns, P. - J., Van Audekerke, J., Guglielmetti, C., Zago, W., Roose, D., Verhoye, M., Van der Linden, A., and Bard, F.,
“Monitoring Blood-Brain Barrier Integrity Following Amyloid-β Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model.”,
J Alzheimers Dis, vol. 54, no. 2, pp. 723-35, 2016.
Â. Rego, Viana, S. D., Ribeiro, C. A. Fontes, Rodrigues-Santos, P., and Pereira, F. C.,
“Monophosphoryl Lipid-A: A Promising Tool for Alzheimer's Disease Toll.”,
J Alzheimers Dis, vol. 52, no. 4, pp. 1189-202, 2016.
M. L. Callisaya, Ayers, E., Barzilai, N., Ferrucci, L., Guralnik, J. M., Lipton, R. B., Otahal, P., Srikanth, V. K., and Verghese, J.,
“Motoric Cognitive Risk Syndrome and Falls Risk: A Multi-Center Study.”,
J Alzheimers Dis, vol. 53, no. 3, pp. 1043-52, 2016.
P. R. Spilman, Corset, V., Gorostiza, O., Poksay, K. S., Galvan, V., Zhang, J., Rao, R., Peters-Libeu, C., Vincelette, J., McGeehan, A., Dvorak-Ewell, M., Beyer, J., Campagna, J., Bankiewicz, K., Mehlen, P., John, V., and Bredesen, D. E.,
“Netrin-1 Interrupts Amyloid-β Amplification, Increases sAβPPα in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease.”,
J Alzheimers Dis, vol. 52, no. 1, pp. 223-42, 2016.
E. Luis, Ortiz, A., Eudave, L., Ortega-Cubero, S., Borroni, B., van der Zee, J., Gazzina, S., Caroppo, P., Rubino, E., D'Agata, F., Le Ber, I., Santana, I., Cunha, G., Almeida, M. R., Boutoleau-Bretonnière, C., Hannequin, D., Wallon, D., Rainero, I., Galimberti, D., Van Broeckhoven, C., Pastor, M. A., and Pastor, P.,
“Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations.”,
J Alzheimers Dis, vol. 53, no. 1, pp. 303-13, 2016.
E. Luis, Ortiz, A., Eudave, L., Ortega-Cubero, S., Borroni, B., van der Zee, J., Gazzina, S., Caroppo, P., Rubino, E., D'Agata, F., Le Ber, I., Santana, I., Cunha, G., Almeida, M. R., Boutoleau-Bretonnière, C., Hannequin, D., Wallon, D., Rainero, I., Galimberti, D., Van Broeckhoven, C., Pastor, M. A., and Pastor, P.,
“Neuroimaging Correlates of Frontotemporal Dementia Associated with SQSTM1 Mutations.”,
J Alzheimers Dis, vol. 53, no. 1, pp. 303-13, 2016.
E. K. Pickett, Koffie, R. M., Wegmann, S., Henstridge, C. M., Herrmann, A. G., Colom-Cadena, M., Lleo, A., Kay, K. R., Vaught, M., Soberman, R., Walsh, D. M., Hyman, B. T., and Spires-Jones, T. L.,
“Non-Fibrillar Oligomeric Amyloid-β within Synapses.”,
J Alzheimers Dis, vol. 53, no. 3, pp. 787-800, 2016.
S. Ramanan, Flanagan, E., Leyton, C. E., Villemagne, V. L., Rowe, C. C., Hodges, J. R., and Hornberger, M.,
“Non-Verbal Episodic Memory Deficits in Primary Progressive Aphasias are Highly Predictive of Underlying Amyloid Pathology.”,
J Alzheimers Dis, vol. 51, no. 2, pp. 367-76, 2016.
E. A. Tanifum, Ghaghada, K., Vollert, C., Head, E., Eriksen, J. L., and Annapragada, A.,
“A Novel Liposomal Nanoparticle for the Imaging of Amyloid Plaque by Magnetic Resonance Imaging.”,
J Alzheimers Dis, vol. 52, no. 2, pp. 731-45, 2016.
J. Marín-Muñoz, Noguera-Perea, M. Fuensanta, Gómez-Tortosa, E., López-Motos, D., Antequera-Torres, M., Martínez-Herrada, B., Manzanares-Sánchez, S., Vivancos-Moreau, L., Legaz-García, A., Del Arroyo, A. Rábano- Gu, and Antúnez-Almagro, C.,
“Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer's Disease.”,
J Alzheimers Dis, vol. 53, no. 1, pp. 73-8, 2016.
H. Marcel Joh Vanderstichele, Janelidze, S., Demeyer, L., Coart, E., Stoops, E., Herbst, V., Mauroo, K., Brix, B., and Hansson, O.,
“Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes.”,
J Alzheimers Dis, vol. 53, no. 3, pp. 1121-32, 2016.
N. Voyle, Keohane, A., Newhouse, S., Lunnon, K., Johnston, C., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., Hodges, A., Kiddle, S., and Dobson, R. Jb,
“A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.”,
J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
N. Voyle, Keohane, A., Newhouse, S., Lunnon, K., Johnston, C., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., Hodges, A., Kiddle, S., and Dobson, R. Jb,
“A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.”,
J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
D. Chiasserini, Biscetti, L., Farotti, L., Eusebi, P., Salvadori, N., Lisetti, V., Baschieri, F., Chipi, E., Frattini, G., Stoops, E., Vanderstichele, H., Calabresi, P., and Parnetti, L.,
“Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
W. Tajeddinn, Persson, T., Calvo-Garrido, J., Ahmed, M. Seed, Maioli, S., Vijayaraghavan, S., Kazokoglu, M. Selim, Parrado-Fernández, C., Yoshitake, T., Kehr, J., Francis, P., Winblad, B., Höglund, K., Cedazo-Minguez, A., and Aarsland, D.,
“Pharmacological Modulations of the Serotonergic System in a Cell-Model of Familial Alzheimer's Disease.”,
J Alzheimers Dis, vol. 53, no. 1, pp. 349-61, 2016.
C. B. Malpas, Vivash, L., Genc, S., Saling, M. M., Desmond, P., Steward, C., Hicks, R. J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N. M., Hovens, C. M., Velakoulis, D., and O'Brien, T. J.,
“A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”,
J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.
] 